Concepedia

Hiromichi Yuki

HY

6

Publications

339

Citations

6

H-Index

2012

Active since

Affiliations

Kumamoto University(Current)

Kumamoto University Hospital

Hiromichi Yuki is an author at Kumamoto University specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2012–2015

6

Publications

6

PDK1 inhibition is a novel therapeutic target in multiple myeloma

Saori Fujiwara, Yawara Kawano, Hiromichi Yuki et al. · British Journal of Cancer · 2012 · 137 citations · Full text

Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide

Yawara Kawano, Shiho Fujiwara, Naoko Wada et al. · International Journal of Oncology · 2012 · 112 citations · Full text

, , +14

PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells

Hiromichi Yuki, Shikiko Ueno, Hiro Tatetsu et al. · Blood · 2012 · 47 citations · Full text

Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans

Taichi Hirano, Yusuke Higuchi, Hiromichi Yuki et al. · Journal of Clinical and Experimental Hematopathology · 2015 · 18 citations · Full text

Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells

Shinya Endo, Masayuki Amano, Nao Nishimura et al. · Biochemical and Biophysical Research Communications · 2015 · 13 citations

, , +9

Rows per page

1–5 of 6